Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about alpha-synuclein burden: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| colon exposure | reduces | process | 0.70 |
| enteric nervous system | modulates | cell_type | 0.70 |
| SCFAS | regulates | drug | 0.70 |
| SCFAs | reduces | metabolite | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Physiological SCFAs may reduce alpha-synuclein burden primar | 0.650 | neurodegeneration | Do physiological concentrations of SCFAs |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-24 | 6 hypotheses Top: 0.670
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning alpha-synuclein burden in their description or question text
No additional research found